Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center

Exclusive Collaboration at Concord's New Cancer Facilities in Shanghai and Beijing, China and in Singapore

News provided by

Concord Medical Services Holdings Limited

May 06, 2015, 08:00 ET

BEIJING, May 6, 2015 /PRNewswire/ -- Concord Medical Services Holdings Limited ("CCM" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has signed a multi-year strategic development agreement with The University of Texas MD Anderson Cancer Center ("MD Anderson"), an internationally renowned cancer research, treatment and education center. CCM and MD Anderson will collaborate to develop a multidisciplinary cancer care, subspecialized and research-driven oncology program and state-of-art oncology facilities to optimize patient experience and improve cancer care in China and Singapore.

MD Anderson will provide CCM with strategic counsel and programmatic services to support the development and implementation of a multidisciplinary oncology program with emphasis on clinical quality, patient safety, training and education, as well as research and development programs. The agreement, which is the first of its kind for MD Anderson in Asia, will be an exclusive collaboration at CCM's new cancer facilities in Shanghai and Beijing, and the collaboration exclusivity will cover most of the provinces in China, and in Singapore. The organizations will also work collaboratively as CCM develops a new cancer hospital in Guangzhou, China.

In the future, CCM's cancer hospitals in China and Singapore will pursue to qualify for MD Anderson Cancer Network's Associate membership program, a co-branded clinical care, research and delivery partnership, which includes clinical integration with MD Anderson.

"We are very pleased to enter into a comprehensive, exclusive collaboration with M.D. Anderson," commented Dr. Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical. "M.D. Anderson, one of the leading cancer hospitals in the U.S., represents the highest standard in cancer treatment and diagnosis. We intend to work together with MDACC's clinical and management teams to introduce MDACC's multidisciplinary treatment and other advanced methodologies, treatment regimens, academic achievements as well as advanced technologies for the benefit of patients in China and Singapore. We also intend to cooperate in research related to high incidence oncology diseases in China, as well as provide international training standards to doctors and research personnel." concluded Dr. Yang.

"There is a significant gap in the quality of treatment and care to cancer patients between the U.S. and China. Through our collaboration with MD Anderson, Concord Medical will continue to enhance its overall standard of care to cancer patients in China," Dr. Yang said.

"Collaboration is vital to realizing our mission of eliminating cancer worldwide. We're pleased to expand our long-standing relationship with Concord Medical and help develop a multidisciplinary, research-driven oncology program," said Dan Fontaine, MD Anderson's Executive Chief of Staff. "Together, we'll work to fight cancer across China and Singapore."

About Concord Medical

Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of December 31, 2014, the Company operated a network of 139 centers with 80 hospital partners that spanned 56 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, The Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute (NCI). For the past 25 years, MD Anderson has ranked as one of the nation's top two cancer centers in U.S. News & World Report's annual "Best Hospitals" survey.

Concord Medical Services

Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
[email protected]

Ms. Fang Liu (Chinese and English)
+86 10 5903 6688 (ext. 639)
[email protected]

ICR Inc.

In China:
Ms. Rene Jiang
+86 10 6583-7521
[email protected]

In the United States:
Mr. William Zima
+1 203-682-8233
[email protected]

SOURCE Concord Medical Services Holdings Limited